Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
STXS Stereotaxis Inc
- Stocks
- Healthcare
- NASDAQ: STXS
Price (delayed)
$2.29
Market cap
$196.94M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.31
Enterprise value
$192.12M
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic
Highlights
STXS's revenue is up by 2.2% from the previous quarter
Stereotaxis's debt has increased by 9% YoY but it has decreased by 2.3% from the previous quarter
STXS's equity has dropped by 80% year-on-year and by 53% since the previous quarter
STXS's quick ratio has shrunk by 64% YoY and by 17% QoQ
Key stats
What are the main financial stats of STXS
Market
Valuations
Earnings
Shares outstanding
86M
Market cap
$196.94M
Enterprise value
$192.12M
Price to earnings (P/E)
N/A
Price to book (P/B)
68.37
Price to sales (P/S)
7.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.98
Revenue
$27.51M
Gross profit
$14.69M
Operating income
-$25.92M
Net income
-$25.36M
EBIT
-$25.36M
EBITDA
-$24.15M
Free cash flow
-$7.96M
Per share
Balance sheet
Liquidity
EPS
-$0.31
EPS diluted
-$0.31
Free cash flow per share
-$0.09
Book value per share
$0.03
Revenue per share
$0.31
TBVPS
$0.4
Total assets
$45.71M
Total liabilities
$37.53M
Debt
$5.87M
Equity
$2.88M
Working capital
$1.68M
Debt to equity
2.04
Current ratio
1.07
Quick ratio
0.62
Net debt/EBITDA
0.2
Margins
Efficiency
Dividend
EBITDA margin
-87.8%
Gross margin
53.4%
Net margin
-92.2%
Operating margin
-94.2%
Return on assets
-59.4%
Return on equity
-342.4%
Return on invested capital
-254.4%
Return on capital employed
-118.1%
Return on sales
-92.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STXS stock price
How has the Stereotaxis stock price performed over time
Intraday
0%
1 week
9.05%
1 month
13.37%
1 year
19.27%
YTD
0.44%
QTD
30.11%
Financial performance
How have Stereotaxis's revenue and profit performed over time
Revenue
$27.51M
Gross profit
$14.69M
Operating income
-$25.92M
Net income
-$25.36M
Gross margin
53.4%
Net margin
-92.2%
The net income has contracted by 28% YoY and by 5% from the previous quarter
Stereotaxis's net margin has decreased by 26% YoY and by 3.2% from the previous quarter
STXS's operating income is down by 24% year-on-year and by 4.8% since the previous quarter
STXS's operating margin is down by 22% YoY and by 2.5% from the previous quarter
Price vs fundamentals
How does STXS's price correlate with its fundamentals
Growth
What is Stereotaxis's growth rate over time
Valuation
What is Stereotaxis stock price valuation
P/E
N/A
P/B
68.37
P/S
7.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.98
The EPS has contracted by 19% YoY and by 3.3% from the previous quarter
STXS's P/B is 141% above its last 4 quarters average of 28.4
STXS's equity has dropped by 80% year-on-year and by 53% since the previous quarter
The stock's price to sales (P/S) is 18% less than its 5-year quarterly average of 8.9 but 11% more than its last 4 quarters average of 6.6
STXS's revenue is up by 2.2% from the previous quarter
Efficiency
How efficient is Stereotaxis business performance
Stereotaxis's return on equity has shrunk by 187% YoY and by 45% QoQ
STXS's return on invested capital has dropped by 83% year-on-year and by 27% since the previous quarter
The ROS has contracted by 26% YoY and by 3.2% from the previous quarter
Stereotaxis's ROA has decreased by 22% YoY
Dividends
What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STXS.
Financial health
How did Stereotaxis financials performed over time
The company's total assets is 22% higher than its total liabilities
STXS's total liabilities has soared by 93% YoY and by 6% from the previous quarter
STXS's quick ratio has shrunk by 64% YoY and by 17% QoQ
Stereotaxis's debt is 104% more than its equity
STXS's debt to equity has soared by 106% since the previous quarter
STXS's equity has dropped by 80% year-on-year and by 53% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.